24 May 2013
Keywords: eisai, anesthetic, approved, fda, subsidiary, japanese, drugmaker
Article | 22 December 2008
The US subsidiary of Japanese drugmaker Eisai says that the Food and Drug Administration has approved its Lusedra (fospropofol disodium)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
© 2013 thepharmaletter.com